Alnylam Pharmaceuticals
ALNY
#634
Rank
$39.51 B
Marketcap
$296.11
Share price
-4.32%
Change (1 day)
8.25%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$7.91 M-81.51%
2025$42.8 M-0.86%
2024$43.18 M-16.96%
2023$51.99 M-66.55%
2022$0.15 B200.46%
2021$51.74 M-9.83%
2020$57.38 M52.34%
2019$37.66 M46.52%
2018$25.7 M-70.97%
2017$88.54 M191.96%
2016$30.32 M-14.94%
2015$35.65 M68.07%
2014$21.21 M152.1%
2013$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
$0.24 B$0.35 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$2.97 M$59.98 M๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
$3.28 M$47.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$4.41 M$20.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/A$3.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.6 M$1.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$8.43 M$83.87 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
$7.77 M$15.32 M๐Ÿ‡บ๐Ÿ‡ธ USA